These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 16546144)
1. Effects of tetrodotoxin (TTX) inactivation of the central nucleus of the amygdala (CNA) on dark period sleep and activity. Sanford LD; Yang L; Liu X; Tang X Brain Res; 2006 Apr; 1084(1):80-8. PubMed ID: 16546144 [TBL] [Abstract][Full Text] [Related]
2. Influence of tetrodotoxin inactivation of the central nucleus of the amygdala on sleep and arousal. Tang X; Yang L; Liu X; Sanford LD Sleep; 2005 Aug; 28(8):923-30. PubMed ID: 16218075 [TBL] [Abstract][Full Text] [Related]
3. Cholinergic regulation of the central nucleus of the amygdala in rats: effects of local microinjections of cholinomimetics and cholinergic antagonists on arousal and sleep. Sanford LD; Yang L; Tang X; Dong E; Ross RJ; Morrison AR Neuroscience; 2006 Sep; 141(4):2167-76. PubMed ID: 16843604 [TBL] [Abstract][Full Text] [Related]
4. Tetrodotoxin inactivation of pontine regions: influence on sleep-wake states. Sanford LD; Yang L; Tang X; Ross RJ; Morrison AR Brain Res; 2005 May; 1044(1):42-50. PubMed ID: 15862788 [TBL] [Abstract][Full Text] [Related]
5. Regulation of dark period sleep by the Amygdala: A microinjection and optogenetics study. Wellman LL; Lonart G; Adkins AM; Sanford LD Brain Res; 2022 Apr; 1781():147816. PubMed ID: 35131286 [TBL] [Abstract][Full Text] [Related]
6. Prolactin microinjections into the amygdalar central nucleus lead to decreased NREM sleep. Sanford LD; Nassar P; Ross RJ; Schulkin J; Morrison AR Sleep Res Online; 1998; 1(3):109-13. PubMed ID: 11382866 [TBL] [Abstract][Full Text] [Related]
7. Amygdaloid control of alerting and behavioral arousal in rats: involvement of serotonergic mechanisms. Sanford LD; Tejani-Butt SM; Ross RJ; Morrison AR Arch Ital Biol; 1995 Dec; 134(1):81-99. PubMed ID: 8919194 [TBL] [Abstract][Full Text] [Related]
8. GABAergic regulation of the central nucleus of the amygdala: implications for sleep control. Sanford LD; Parris B; Tang X Brain Res; 2002 Nov; 956(2):276-84. PubMed ID: 12445696 [TBL] [Abstract][Full Text] [Related]
9. Effects of microinjections of Group II metabotropic glutamate agents into the amygdala on sleep. Dong E; Wellman LL; Yang L; Sanford LD Brain Res; 2012 May; 1452():85-95. PubMed ID: 22453124 [TBL] [Abstract][Full Text] [Related]
10. Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat. Cavas M; Navarro JF Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):668-78. PubMed ID: 16457926 [TBL] [Abstract][Full Text] [Related]
11. Sleep-related neurons in the central nucleus of the amygdala of rats and their modulation by the dorsal raphe nucleus. Jha SK; Ross RJ; Morrison AR Physiol Behav; 2005 Nov; 86(4):415-26. PubMed ID: 16137725 [TBL] [Abstract][Full Text] [Related]
13. Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Thakkar MM; Engemann SC; Walsh KM; Sahota PK Neuroscience; 2008 Jun; 153(4):875-80. PubMed ID: 18440150 [TBL] [Abstract][Full Text] [Related]
14. Compensatory sleep responses to wakefulness induced by the dopamine autoreceptor antagonist (-)DS121. Olive MF; Seidel WF; Edgar DM J Pharmacol Exp Ther; 1998 Jun; 285(3):1073-83. PubMed ID: 9618410 [TBL] [Abstract][Full Text] [Related]
15. Influence of fear conditioning on elicited ponto-geniculo-occipital waves and rapid eye movement sleep. Sanford LD; Silvestri AJ; Ross RJ; Morrison AR Arch Ital Biol; 2001 Apr; 139(3):169-83. PubMed ID: 11330199 [TBL] [Abstract][Full Text] [Related]
16. Effects on sleep of melanin-concentrating hormone (MCH) microinjections into the dorsal raphe nucleus. Lagos P; Torterolo P; Jantos H; Chase MH; Monti JM Brain Res; 2009 Apr; 1265():103-10. PubMed ID: 19230831 [TBL] [Abstract][Full Text] [Related]
17. The visual scoring of sleep and arousal in infants and children. Grigg-Damberger M; Gozal D; Marcus CL; Quan SF; Rosen CL; Chervin RD; Wise M; Picchietti DL; Sheldon SH; Iber C J Clin Sleep Med; 2007 Mar; 3(2):201-40. PubMed ID: 17557427 [TBL] [Abstract][Full Text] [Related]
18. Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption. Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M J Psychopharmacol; 2009 Jul; 23(5):475-86. PubMed ID: 19395429 [TBL] [Abstract][Full Text] [Related]
19. Antagonizing corticotropin-releasing factor in the central nucleus of the amygdala attenuates fear-induced reductions in sleep but not freezing. Liu X; Wellman LL; Yang L; Ambrozewicz MA; Tang X; Sanford LD Sleep; 2011 Nov; 34(11):1539-49. PubMed ID: 22043125 [TBL] [Abstract][Full Text] [Related]
20. [The action profile of D,L-kavain. Cerebral sites and sleep-wakefulness-rhythm in animals]. Holm E; Staedt U; Heep J; Kortsik C; Behne F; Kaske A; Mennicke I Arzneimittelforschung; 1991 Jul; 41(7):673-83. PubMed ID: 1772452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]